Naltrexone SR/Bupropion SR Combination Therapy Reduces Total and Visceral Adiposity in Overweight and Obese Subjects in the COR-I Study

被引:0
|
作者
Smith, Steven R.
Church, Timothy
Geohas, Jeffrey
Griffin, Carl
Harper, Wayne L.
Krieger, Diane
Loper, Judy F.
Mudaliar, Sunder
Woodruff, Chivers
Guttadauria, Maria
Henry, Eugenia
Kim, Dennis D.
Dunayevich, Eduardo
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A483 / A483
页数:1
相关论文
共 34 条
  • [1] Naltrexone SR/Bupropion SR Combination Therapy Improves Control of Eating and Reduces Food Cravings in Overweight/Obese Subjects
    Fujioka, Ken
    Greenway, Frank L.
    Billes, Sonja K.
    Burns, Colleen
    Harris-Collazo, Raul
    Kim, Dennis D.
    Dunayevich, Eduardo
    OBESITY, 2010, 18 : S152 - S152
  • [2] Naltrexone SR/Bupropion SR Combination Therapy Improves Control of Eating and Reduces Food Cravings in Overweight and Obese Subjects
    Hill, James O.
    Wyatt, Holly
    Billes, Sonja K.
    Burns, Colleen
    Harris-Collazo, Raul
    Dunayevich, Eduardo
    Blundell, John
    DIABETES, 2011, 60 : A506 - A506
  • [3] Combination therapy with naltrexone and bupropion for obesity reduces total and visceral adiposity
    Smith, S. R.
    Fujioka, K.
    Gupta, A. K.
    Billes, S. K.
    Burns, C.
    Kim, D.
    Dunayevich, E.
    Greenway, F. L.
    DIABETES OBESITY & METABOLISM, 2013, 15 (09): : 863 - 866
  • [4] An Open-Label Study Evaluating the Naltrexone SR/Bupropion SR Combination Therapy in Overweight or Obese Subjects with Major Depression
    McElroy, Susan L.
    Guerdjikova, Anna I.
    Rosen, Amy
    Kim, Dennis D.
    Landbloom, Ronald
    Dunayevich, Eduardo
    DIABETES, 2010, 59 : A483 - A484
  • [5] Improved Glycemic Control and Weight Loss with Naltrexone SR/Bupropion SR Combination Therapy in Overweight/Obese Subjects with Type 2 Diabetes
    Gupta, Alok K.
    Hollander, Priscilla
    Bays, Harold
    Guttadauria, Maria
    Erickson, Janelle
    Kim, Dennis
    Dunayevich, Eduardo
    DIABETES, 2010, 59 : A687 - A687
  • [6] Naltrexone SR/Bupropion SR Combination Therapy Reduced Weight and Improved Weight-Related Quality of Life and Physical Health in Overweight and Obese Subjects
    Kolotkin, Ronette L.
    Still, Christopher
    Maier, Holly
    Burns, Colleen
    Harris-Collazo, Raul
    Dunayevich, Eduardo
    Aronne, Louis J.
    DIABETES, 2011, 60 : A506 - A507
  • [7] COR-Diabetes: Naltrexone SR/Bupropion SR Combination Therapy Led to Significant and Sustained Weight Loss and Improved HbA1c in Overweight/Obese Subjects with Type 2 Diabetes
    Hollander, Priscilla
    Plodkowski, Raymond
    Gupta, Alok K.
    Guttadauria, Maria
    Erickson, Janelle
    Kim, Dennis
    Dunayevich, Eduardo
    DIABETES, 2010, 59 : A15 - A15
  • [8] Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
    Wadden, Thomas A.
    Foreyt, John P.
    Foster, Gary D.
    Hill, James O.
    Klein, Samuel
    O'Neil, Patrick M.
    Perri, Michael G.
    Pi-Sunyer, F. Xavier
    Rock, Cheryl L.
    Erickson, Janelle S.
    Maier, Holly N.
    Kim, Dennis D.
    Dunayevich, Eduardo
    OBESITY, 2011, 19 (01) : 110 - 120
  • [9] An open-label study of naltrexone and bupropion combination therapy for smoking cessation in overweight and obese subjects
    Wilcox, Charles S.
    Oskooilar, Nader
    Erickson, Janelle S.
    Billes, Sonja K.
    Katz, Barbara B.
    Tollefson, Gary
    Dunayevich, Eduardo
    ADDICTIVE BEHAVIORS, 2010, 35 (03) : 229 - 234
  • [10] Reduced Depressive Symptoms and Weight Loss in Depressed Overweight/Obese Subjects Completing 24 Weeks of Open Label Therapy With Naltrexone SR/Bupropion SR
    McElroy, Susan L.
    Guerdjikova, Anna
    Mignon, Laurence
    Burns, Colleen
    Kim, Dennis D.
    Landbloom, Ronald
    Dunayevich, Eduardo
    OBESITY, 2010, 18 : S152 - S152